tradingkey.logo
tradingkey.logo
検索

Dr Reddy's Laboratories Ltd

RDY
ウォッチリストに追加
11.850USD
+0.015+0.13%
終値 07-31 16:00ET15分遅れの株価
10.03B時価総額
20.33直近12ヶ月PER

詳細情報 Dr Reddy's Laboratories Ltd 企業名

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Dr Reddy's Laboratories Ltdの企業情報

企業コードRDY
会社名Dr Reddy's Laboratories Ltd
上場日Jan 01, 1986
最高経営責任者「CEO」Aghanian (Patrick)
従業員数27811
証券種類Depository Receipt
決算期末Jan 01
本社所在地8-2-337, Road No.3 Banjara Hills
都市HYDERABAD
証券取引所NASDAQ OMX NASDAQ Basic NYSE
India
郵便番号500-034
電話番号914049002900
ウェブサイトhttps://www.drreddys.com/
企業コードRDY
上場日Jan 01, 1986
最高経営責任者「CEO」Aghanian (Patrick)

Dr Reddy's Laboratories Ltdの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Gunupati Venkateswa Prasad
Mr. Gunupati Venkateswa Prasad
Executive Co-Chairman, Managing Director
Executive Co-Chairman, Managing Director
--
--
Mr. Kallam Satish Reddy
Mr. Kallam Satish Reddy
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. M. V. Ramana
Mr. M. V. Ramana
Chief Executive Officer, Branded Markets (India and Emerging Markets)
Chief Executive Officer, Branded Markets (India and Emerging Markets)
--
--
Mr. Erez Israeli
Mr. Erez Israeli
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Shikha Sanjaya Sharma
Ms. Shikha Sanjaya Sharma
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Leo Puri
Mr. Leo Puri
Lead Non-Executive Independent Director
Lead Non-Executive Independent Director
--
--
Mr. Sanjay Sharma
Mr. Sanjay Sharma
Head - Global Operations
Head - Global Operations
--
--
Mr. Deepak Sapra
Mr. Deepak Sapra
Chief Executive Officer - API and Services
Chief Executive Officer - API and Services
--
--
Mr. Patrick Aghanian
Mr. Patrick Aghanian
Chief Executive Officer, European Generics
Chief Executive Officer, European Generics
--
--
Kodumudi Pranatharthiharan Krishnan
Kodumudi Pranatharthiharan Krishnan
Non-Executive Independent Director
Non-Executive Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Gunupati Venkateswa Prasad
Mr. Gunupati Venkateswa Prasad
Executive Co-Chairman, Managing Director
Executive Co-Chairman, Managing Director
--
--
Mr. Kallam Satish Reddy
Mr. Kallam Satish Reddy
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. M. V. Ramana
Mr. M. V. Ramana
Chief Executive Officer, Branded Markets (India and Emerging Markets)
Chief Executive Officer, Branded Markets (India and Emerging Markets)
--
--
Mr. Erez Israeli
Mr. Erez Israeli
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Shikha Sanjaya Sharma
Ms. Shikha Sanjaya Sharma
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Leo Puri
Mr. Leo Puri
Lead Non-Executive Independent Director
Lead Non-Executive Independent Director
--
--

よくある質問

Dr Reddy's Laboratories Ltdの上位5名の株主は誰ですか?

Dr Reddy's Laboratories Ltdの上位5名の株主は以下のとおりです。Dr. Alpna Hansraj Seth, Ph.D.

Dr Reddy's Laboratories Ltd(RDY)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Dr Reddy's Laboratories Ltdの株式を保有している機関は538社あり、保有株式の総市場価値は約117.02Mで、全体の14.05%を占めています。2025Q4と比較して、機関の持ち株は-9217065.00増加しています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。